NXP Semiconductors N.V. Common Stock vs 10X Genomics Inc — how do they compare? NXP Semiconductors N.V. Common Stock trades at $227.52 (market cap $58.27B), while 10X Genomics Inc trades at $80.65 (market cap $10.07B). The key difference: NXP Semiconductors N.V. Common Stock is far larger — about 5.8× 10X Genomics Inc's market cap, and NXP Semiconductors N.V. Common Stock pays a 1.76% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold NXP Semiconductors N.V. Common Stock for 0 Days and 10X Genomics Inc for 91 Days on average.
| NXPI | TXG | |
|---|---|---|
Market Cap | $58.27B | $10.07B |
Volume | 3,950,702 | 5,657,286 |
Sector | Technology | Health |
52-Week High | $332.67 | $97.74 |
52-Week Low | $184.19 | $11.48 |
Typical Hold Time | 0 Days | 91 Days |
Enterprise Value | $66.38B | $9.59B |
Dividend Yield | 1.76% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
10x Genomics (TXG) trades at $77.28, up 1.55% on the day, with a bearish technical signal from moving averages. The company shows improving fundamentals with revenue of $642.82M in 2025 and a reduced net loss of -$43.54M, while recent news highlights strong demand for its Atera spatial biology platform and a patent victory. Positive earnings beats in recent quarters contrast with a high EV/EBITDA of 249.22, indicating significant growth expectations are priced in.
The outlook is mixed; analyst consensus is neutral with a $74.30 price target slightly below the current price, yet operational cash flow turned strongly positive in 2025. Key risks include persistent net losses, high valuation multiples, and execution on new product launches. The stock's near-term direction hinges on Atera's commercial success and achieving profitability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
NXP Semiconductors designs semiconductor solutions for embedded applications. Its products serve automotive, industrial and IoT, mobile, and communications-infrastructure markets.
Read more on NXPI →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →